For Merck Chief, Credibility at the Capitol
229610
Something finally went right yesterday for Raymond V. Gilmartin, the embattled chairman and chief executive of Merck &amp; Company.
552
House members can choose from an array of ready-made aids, but many draw from personal experience of constituents.
453249
Law &amp; Order: Pharmaceutical Unit. Merck (nyse: MRK - news - people ) Chief Executive Raymond V. Gilmartin may testify in some of the many lawsuits filed over the Vioxx recall, a company lawyer said.
510588
BOSTON (CBS.MW) -- Pharmaceutical behemoth Merck heads to Capitol Hill Thursday to testify at a Senate hearing on whether the government should have forced the drugmaker to withdraw its Vioxx drug from the market before late September.
496967
The House Energy and Commerce Committee is investigating how Vioxx was approved and then taken off the market. It has written to Lester Crawford, FDA, and Ray Gilmartin, CEO of Merck, requesting documents about Vioxx.
200022
NEW YORK, Nov. 29 -- Drugmaker Merck & Co., under financial siege since pulling its top painkiller Vioxx off the market in September, said Monday it has adopted a plan that would guarantee large severance packages to 230 top executives if the company merges or is taken over.
602739
WASHINGTON -- Local biotech powerhouses were comforted by yesterday's congressional testimony that urged federal regulators to take a cautious approach to approving generic versions of biologics, including mandatory human clinical trials.
535409
As Ben S. Bernanke, the chairman of the Federal Reserve, meets with policy makers to set interest rates this week, it is clear that he has earned credibility with Wall Street.
94086
US drugs regulators made two trips to Capitol Hill last week to defend themselves before Congress. They are likely to return soon, after their efforts to reassure lawmakers and the public
6842
Despite calls from medical experts and a prominent Republican senator for an independent office to monitor drug safety, the idea, prompted by the Food and Drug
196378
A top Republican lawmaker on  Wednesday called on Merck & Co. Inc. to answer questions about  its withdrawn drug Vioxx at the first congressional hearing on  Nov. 18 to address the arthritis medicine's safety problems.
510630
The first call Sheldon Goldberg got on his first day as president of the Alzheimer's Association was not from a patient or a doctor but from Michael D. Bromberg, chairman of the Capitol Health Group, a well-connected Washington lobbying firm.
745093
Lawmakers expressed hope that Dr. Andrew C. von Eschenbach's leadership would bring stability to the agency.
679017
A week after saying it was withdrawing its $2.5 billion arthritis drug Vioxx from the market and losing a quarter of its stock market value as a result, Merck &amp; Co. will try to dodge the storm clouds and turn its attention tomorrow to a brighter subject with the official opening of its Boston research lab.
439311
PHILADELPHIA -- Most of the 250 lawyers assembled in the Wyndham Philadelphia hotel ballroom listened intently yesterday as fellow attorney Barry Hill showed off an extensive collection of trinkets and product samples emblazoned with the logo of the now-withdrawn drug Vioxx.
429824
TRENTON, N.J. - Pharmaceutical giant Merck & Co...
431979
Amid questions about whether the arthritis drug Vioxx was taken off the market soon enough, a key senator suggested Friday that an independent